Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: ACS Chem Neurosci. 2021 Oct 15;12(21):3972–3984. doi: 10.1021/acschemneuro.1c00524

Table 3.

Stimulation of Autophagy Was Induced by Numerous Small Molecules and Previously FDA-Approved Drugs in Various Models of HD and PD

compd ND model model system FDA-approved other purpose putative target/mechanism ref
5 HD Mammalian cell models Y antipsychotic Inhibits dopaminergic D2 receptor 57
6 HD Y Blocking adrenergic and dopaminergic neural transmission (23); inhibit excitotoxicity of glutamate (25) 57
7 HD Y Aminergic receptors 57
8 HD Y Cardiac indications Inhibitors of intracellular Ca2+ current 57
9 HD Y 57
10 HD Y
11 HD, PD Y Diarrhea μ-Opioid receptor agonist; blocks Ca2+ channels in vitro cellular experiments (27, 28) 55, 57
12 HD N Neurotoxin Irreversible blocker of Ca2+-activated K+ channel 57
13 HD, PD Y Hypertension L-type Ca2+-channel antagonist 55
14 HD, PD Y Hypertension L-type Ca2+-channel antagonist 55
15 HD, PD Y Sedative, hypertension α2-adrenergic and ILR receptor agonist 55
16 HD, PD Y Vasodilator ATP-sensitive K+ channel agonist 55
17 HD, PD Yeast, mammalian cells, Drosophila na 47
18 HD, PD na 47
19 HD, PD na 47
20 PD Mammalian cells na 104